Press release
Injectable Drug Delivery Market Explores New Growth Opportunities By 2015 - 2025
Injectable drug delivery is defined as administration of a drug or drugs directly into patient’s blood circulationthrough a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response. The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system. Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic.Major routes for injectable drug delivery include intravenous, intramuscular, intraarterial, intracardiac, subcutaneous, intradermal, intra peritoneal, intrathecal amongst others. Many medications such as antibiotics, peptides and protein, vaccine and gene based drugs, in general are delivered using this route due to their susceptible to enzymatic degradation or poor and inefficient absorption into the systemic circulation due to molecular size and charge,thus leading to their therapeutic effectiveness.Technological advancement, surge of biologics, rising incidences of diseases such as cancer and diabetes and improving patient compliance to injectable drug delivery are some of the major factors driving this market. However product recalls, patient safety issues, anddevelopment of alternate drug delivery methods, are some of the key deterrents posing a challenge to the growth of global injectable drug delivery market.Manufacturing cost of this drug delivery system is expensive as compared to conventional tablets and capsules. A sudden increase in serum concentration of drug post injection of drug may lead to toxicity. Self injection requires adequate patient training and may initially suffer from pain and infection at the site of injection.
Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-393
The global injectable drug delivery market has been segmented based on indication, formulations, device type and geography. Injectable drug delivery has been used for various indications such as aesthetics, autoimmune diseases, hormonal disorders, infectious diseases, oncology and pain management. Injectable drug delivery systems may be formulated into conventional drug delivery such as suspensions, emulsions,and oil solutions while novel systems includeliposome, microspheres, and nanoparticles. Various devices in the injectable drug delivery include disposables &reusable, fill-able and prefilled, and self injection devices such as needle free, pen and auto injectors. Geographically, the market has been segmented in to four major regions namely, North America, Europe, Asia-Pacific and Rest of the World.
Some of the drugs that are commonly administered by injectable drug delivery include analgesics, antibiotics, immunosuppressive agents, antihypertensive agents, vasodilators, chemotherapeutic agents and antiarrhythmic drugs. Novel systems which involve injectable controlled drug delivery are formulated using biodegradable polymers since they undergo degradation in the body without any requirement for removal. Biodegradable polymers used are of natural or synthetic origin. The release can either be continuous or pulsatile depending on the structure of the device and the polymer characteristics.
Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-393
The key players contributing to the global injectable drug delivery market include Antares Pharma, Inc., Baxter International, Inc., Becton, Dickinson & Co., Eli Lilly & Company, Hospira, Inc., Novo Nordik A/S, Sanofi SA, Scandinavian Health Limited, Schott AG, Terumo Corporation, Unilife Corporation and Zogenix, Inc.
ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Injectable Drug Delivery Market Explores New Growth Opportunities By 2015 - 2025 here
News-ID: 921486 • Views: …
More Releases from Future Market Insights

Polygon Mirror Scanner Motor Market Set to Hit USD 88.5 Million by 2035, Powered …
The global polygon mirror scanner motor market is experiencing robust growth, forecasted to rise from USD 55.9 million in 2025 to USD 88.5 million by 2035, which represents a nearly 1.6-fold increase over the assessment period. This remarkable expansion is shaped by the widespread adoption of next-generation scanning technologies and the rapid digital transformation across the printing and office equipment industries. As businesses renew their focus on speed, accuracy, and…

Global p-Hydroxybenzoic Acid Market to Approach USD 400 Million by 2035, Driven …
The global p-Hydroxybenzoic Acid (PHBA) market is entering a new era of growth, expected to rise from USD 213.0 million in 2025 to USD 399.8 million by 2035, showcasing a compound annual growth rate of 6.5%. This surge is underpinned by PHBA's flourishing adoption in polymer synthesis, textile processing, and supporting industries seeking high-performance and sustainable chemical solutions. As organizations shift towards advanced materials with enhanced durability, thermal stability, and…

Sustainable Growth Drives Castor Oil Polyol Market to USD 418.8 Million by 2035 …
The castor oil polyol market is set to reshape the landscape of bio-based chemicals, growing from a value of USD 254.7 million in 2025 to USD 418.8 million by 2035. This represents a robust CAGR of 5.1% over the decade, with expansion driven by surging demand across chemical, automotive, construction, and coatings sectors. The market's early growth, spanning 2021 to 2025, reflects steady adoption as sustainable polyols substitute petroleum-based alternatives,…

Global Fifth Wheel Coupling Market to Hit USD 1.2 Billion by 2035 Driven by Smar …
The global Fifth Wheel Coupling Market continues to evolve as the logistics and transport sectors demand more efficient, safe, and smart towing systems. Valued at USD 547.3 million in 2020 and reaching USD 672.6 million by 2024, the market is projected to expand at a 6.0% CAGR from 2025 to 2035, ultimately achieving a valuation of USD 1,238.6 million.
At the heart of this growth lies the critical role of fifth…
More Releases for Injectable
Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I …
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate?
The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes.
The small…
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In …
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028
The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis.
The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that…
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics…
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…